The Nice-based biotech Roca Therapeutics reaches a new milestone in its development

biotech niçoise Roca Therapeutics

A European recognition for a neglected disease: Roca Therapeutics has obtained from the European Medicines Agency (EMA) the orphan drug designation for its drug candidate RCT002. This status marks the official recognition of radiation maculopathy as a disease in its own right, after having long been considered only a complication. This advancement enables reinforced regulatory […]

Health Afterwork in Nice: connecting innovators in the HealthTech sector

Afterwork-Life-Science-Nice-Cote-dAzur-2

Team Nice Côte d’Azur, with the commitment of Sana Bouyahia, Head of Project Development Health and Sports, organized a structuring afterwork event to strengthen synergies among stakeholders in the health sector. The initiative was launched by Medpackinter, a new pharmaceutical manufacturer established in Nice in 2024 with the support of Team Nice Côte d’Azur, as […]

Caranx Medical receives FDA clearance for its AI software guiding heart valve implantation

caranx medical TAVIPILOT Soft

Caranx Medical, a French medtech company based in Nice, has received U.S. FDA clearance for the world’s first AI-powered software for real-time intraoperative guidance during transcatheter aortic valve implantation (TAVI). This marks a significant regulatory milestone for Caranx and for France: it is the first time an AI software from a French company has been […]

Klava Innovation and Isis Medical: a partnership serving respiratory health

klava innovation isis medical

Klava Innovation is integrating its digital therapy Quitoxil® into the home care services of Isis Medical The partnership targets patients with chronic respiratory conditions. An initial deployment phase has begun within the Isis Medical network, particularly in the Languedoc-Roussillon region. A strategic partnership focused on smoking cessation Klava Innovation, a Nice-based medtech company specializing in […]

Paul Martingell new Chief Executive Officer of the Virbac Group

Paul Martingell nommé directeur général du groupe Virbac

Virbac announces the appointment of Paul Martingell as chief executive officer of the Virbac Group, effective September 1, 2025. Paul Martingell, 45, is a recognized leader who has demonstrated his ability to unite international teams, manage complexity, and create value. Holder of an MBA with distinction in mergers and acquisitions and a chartered accountant in […]

Team Nice Côte d’Azur at Viva Technology 2025: at the heart of technological transitions and international attractiveness

Viva-Technology-2025

From June 11 to 14, 2025, Paris hosted Viva Technology, the largest European trade show dedicated to technological innovation. With more than 165,000 visitors, the event brought together startups, investors, public decision-makers and major companies around the technologies of tomorrow. The 2025 edition was particularly marked by international openness and major digital, ecological and industrial […]

Business Landing Nice Côte d’Azur: Support for business set up in France

Key elements of the Business Landing Nice Côte d’Azur scheme financial aid of up to €150,000 for SMEs and micro-enterprises wishing to establish themselves in Nice Côte d’Azur an economic ecosystem structured around strategic sectors personalised support from a strong local partnership network Find the access conditions for the scheme on the Nice Côte d’Azur […]

Bpifrance in Provence–Alpes–Côte d’Azur: 6,432 businesses supported in 2024

bpifrance-paca-2022

In 2024, Bpifrance supported 6,432 businesses in the Provence–Alpes–Côte d’Azur region, mobilizing a total of €2 billion. Strategic industrial projects received €198 million in funding, benefiting 414 companies. Environmental transition tools gained traction with 179 climate diagnostics and €17 million in dedicated loans. Support for business creation accelerated, with nearly 16,000 entrepreneurs supported and the […]